Invex Therapeutics Ltd. (AU:IXC) has released an update.
Invex Therapeutics Ltd., a company focusing on innovative health solutions, has declared full compliance with the ASX Corporate Governance Council’s recommendations for the fiscal year ending June 30, 2024. The details of their corporate governance practices are accessible through their website, ensuring transparency and accountability to their stakeholders. The company’s commitment to these principles is affirmed through its recent update, which has been approved by the board as of August 22, 2024.
For further insights into AU:IXC stock, check out TipRanks’ Stock Analysis page.
